Paolini John F. bought KNSA
August 6, 2025 · Form 4 insider transaction
Paolini John F. bought 29,325 shares of Kiniksa Pharmaceuticals International, plc at $3.80 per share, a transaction worth $111.4K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
29,325
Price
$3.80
Total value
$111.4K
InsiderPaolini John F.
RoleOfficer
SecurityClass A Ordinary Share
Transaction codeM: Option exercise
Transaction dateAugust 6, 2025
Filing dateAugust 8, 2025
Shares owned after86,728
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on May 16, 2024.